CD274 and adrenal cortex carcinoma: Three separate studies of primary and R/M ACC reported that none of the samples analyzed were significantly PD-L1-positive by immunohistochemistry (n = 36, 21, and 24); tumors with CPS ≥ 1 are thus a significant minority of ACC patients [33,38,39].